Growing community of inventors

Madrid, Spain

Rosario Machado Pinilla

Average Co-Inventor Count = 5.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Rosario Machado PinillaIsabel Sanchez Perez (2 patents)Rosario Machado PinillaJose Ramon Murguia Ibanez (2 patents)Rosario Machado PinillaLeandro Sastre Garzon (2 patents)Rosario Machado PinillaRosario Perona Abellon (2 patents)Rosario Machado PinillaRosario Perona Abellón (1 patent)Rosario Machado PinillaIsabel Sánchez Pérez (0 patent)Rosario Machado PinillaLeandro Sastre Garzón (0 patent)Rosario Machado PinillaJosé Ramón Murguia IBÁÑEZ (0 patent)Rosario Machado PinillaRosario Machado Pinilla (2 patents)Isabel Sanchez PerezIsabel Sanchez Perez (2 patents)Jose Ramon Murguia IbanezJose Ramon Murguia Ibanez (2 patents)Leandro Sastre GarzonLeandro Sastre Garzon (2 patents)Rosario Perona AbellonRosario Perona Abellon (2 patents)Rosario Perona AbellónRosario Perona Abellón (1 patent)Isabel Sánchez PérezIsabel Sánchez Pérez (0 patent)Leandro Sastre GarzónLeandro Sastre Garzón (0 patent)José Ramón Murguia IBÁÑEZJosé Ramón Murguia IBÁÑEZ (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Consejo Superior De Investigaciones Cientificas (2 from 453 patents)

2. Universidad Politècnica De València (2 from 57 patents)

3. Universidad Autonoma De Madrid - Fundacion General (2 from 2 patents)

4. Universidad Autónoma De Madrid (30 patents)


2 patents:

1. 9587002 - Sequence of nucleotides and peptides GSE 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof

2. 9074194 - Sequence of nucleotides and peptides GSE 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/16/2025
Loading…